简体中文 | 繁體中文 | English

Products & Services News

2019-10-08 20:16 Telaria and Consortium of Australian Publishers Announce Launch of ‘Editorial Video Marketplace’
2019-10-08 15:47 GSMA: $212 Billion Boost to Asia-Pacific GDP at Stake at WRC-19
2019-10-08 14:57 U.S. Army Awards $35.1 Million Contract to FLIR Systems for New Chemical Agent Disclosure Spray
2019-10-08 14:53 Toshiba Launches 600V Sine-Wave PWM Driver IC for Three-Phase Brushless Motors
2019-10-08 14:21 Visit Korea Committee: Promotions for Flight Ticket, Accommodation, Activity Program Now in Place for Korea Grand Sale 2020
2019-10-08 14:18 E-World Tech, Metal Etching Company, to Enter US Market
2019-10-08 14:11 Bacardi Announces European Launch of Shake Your Future, a Life-changing Experience Giving the Unemployed a New Start in Mixology
2019-10-08 13:22 Vertexcom Builds Large-Scale Wi-SUN FAN Mesh Network With More Than 1000 Nodes
2019-10-08 12:03 MPEG LA Announces Peer Reviewed Article Featured in Nucleic Acid Therapeutics
2019-10-08 10:58 Update of Summary of Product Characteristics for Nuwiq® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis
2019-10-08 09:58 The Cyberthreat Handbook: Thales and Verint Release Their "Who's Who" of Cyberattackers
2019-10-08 09:04 Shinho Engineering Model Launching Brand in Europe and America
2019-10-08 08:11 Kioxia Officially Begins Operations
2019-10-08 08:09 New data reinforces benefits of Spiolto® Respimat® in improving patient outcomes
2019-10-08 08:07 Servier acquires non-Hodgkin B-cell lymphoma treatment PIXUVRI® (pixantrone) from CTI BioPharma, strengthening the Servier oncology portfolio
2019-10-01 21:00 Mercatus Achieves Major Milestone in Japan
2019-10-01 10:01 Hotel Hankyu RESPIRE OSAKA Opens on Wednesday, November 27, 2019
2019-09-30 18:03 Iochpe-Maxion Joins New Mobility Ecosystem with Innovation Office in Berlin
2019-09-30 17:37 Thales Expands Advanced Access Management Capabilities for Authentication Customers to Take on Evolving Threat Landscape
2019-09-30 14:48 INBUILD® meets primary endpoint - study evaluated nintedanib in patients across a range of progressive fibrosing interstitial lung diseases1

Business Wire Weibo

Press Releases

Latest Releases